| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.104 | 18 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.8451 | 44 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.8159 | 56 |
| GSM780719 | Untreated after 4 days (C1_2) | 39.9133 | 6 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.5486 | 20 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.7088 | 16 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.036 | 32 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.2475 | 23 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.3775 | 38 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.5202 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 33.6689 | 1 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.7274 | 26 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.2487 | 55 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 42.4147 | 15 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.9469 | 13 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.4717 | 11 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.3533 | 34 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.1563 | 14 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.1824 | 38 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.4892 | 11 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.5054 | 39 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.8195 | 9 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.8603 | 45 |